Regeneron Announces Important Advances in Novel COVID-19 Antibody Program
Go back to Regeneron Announces Important Advances in Novel COVID-19 Antibody Program| Regeneron (NASDAQ: REGN) | Delayed: 796.60 +15.11 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $781.49 | 52 Week High | $592.36 | |||
| Open | $791.98 | 52 Week Low | $325.35 | |||
| Day High | $798.18 | P/E | 209.08 | |||
| Day Low | $779.45 | EPS | $3.81 | |||
| Volume | 198,343 | |||||

